SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Patent Owner

Follow Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 46204
 
 
 
C07K PEPTIDES 2498
 
 
 
C07D HETEROCYCLIC COMPOUNDS 17127
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 11143
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 10179
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 648
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 6123
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5109
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 488
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 496

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0232,293 DRUG SENSITIVITY BIOMARKERS AND METHODS OF IDENTIFYING AND USING DRUG SENSITIVITY BIOMARKERSOct 17, 14Aug 11, 16[G06F, G01N]
2016/0214,951 EBI2 MODULATORSSep 26, 14Jul 28, 16[C07F, C07D]
2016/0184,447 CAR Peptide for Homing, Diagnosis & Targeted Therapy for Pulmonary and Fibrotic DisordersNov 10, 15Jun 30, 16[C12Q, A61K]
2016/0176,875 SPIROCYCLIC EBI2 MODULATORSSep 26, 14Jun 23, 16[C07F, C07D]
2016/0145,308 Compositions and Methods for Targeted Endometriosis TreatmentJun 11, 14May 26, 16[A61K, C07K]
2016/0022,831 Peptides that Selectively Home to Heart Vasculature and Related Conjugates and MethodsMar 22, 15Jan 28, 16[A61K, C07K]
2015/0353,603 ENDOMETRIOSIS CELL TARGETING PEPTIDE AND USES THEREOFApr 10, 15Dec 10, 15[G01N, A61K, C07K]
2015/0329,497 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1Dec 19, 13Nov 19, 15[C07D, A61K]
2015/0307,499 INHIBITOR OF APOPTOSIS PROTEIN (IAP) ANTAGONISTSNov 26, 13Oct 29, 15[C07D]
2015/0266,842 METHODS AND COMPOSITIONS RELATED TO A RETINOID RECEPTOR-SELECTIVE PATHWAYMay 06, 11Sep 24, 15[C07D, C07C]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,410,128 Method and compounds for generation of iPSCsFeb 22, 12Aug 09, 16[C12N, C07H, G01N]
9,320,810 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cellsOct 30, 13Apr 26, 16[A61K, C07K]
9,266,828 Inhibitors of Furin and other pro-protein convertasesMar 14, 13Feb 23, 16[A61P, C07C, A61K, C07K]
9,238,654 Singleton inhibitors of sumoylation enzymes and methods for their useMay 09, 13Jan 19, 16[C07D, A61K]
9,238,815 Compositions and methods for inhibiting human host factors required for influenza virus replicationDec 10, 10Jan 19, 16[C12N, A61K]
9,233,926 Compounds for stem cell differentiationMar 23, 12Jan 12, 16[C07D, A61K]
9,193,710 Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereofAug 29, 12Nov 24, 15[C07D, A61K]
9,180,161 CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disordersFeb 28, 11Nov 10, 15[A61K, C07K]
9,120,787 HIV replication inhibitorsAug 27, 12Sep 01, 15[C07D, A61K]
9,115,170 Methods and compositions related to internalizing RGD peptidesJan 30, 13Aug 25, 15[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0051,138 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASESABANMar 14, 13Feb 19, 15[C07K]
2014/0243,387 METHODS FOR IMPROVING CARDIAC CONTRACTILITYABANDec 17, 13Aug 28, 14[C12N, G01N]
2014/0134,231 MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMAABANMar 15, 13May 15, 14[C12N, C12Q, A61K]
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USEABANSep 28, 11Aug 29, 13[C07K]
2013/0225,427 METHOD FOR PREDICTION OF RESPONSE TO IMMUNE MEDIATED DISEASE THERAPEUTICSABANNov 07, 12Aug 29, 13[C12Q, G01N]
2013/0210,124 DETERMINATION OF CANCER PREDISPOSITIONABANFeb 08, 13Aug 15, 13[G06F]
2013/0183,241 PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAMEABANDec 10, 12Jul 18, 13[A61K]
2013/0157,260 IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSISABANDec 02, 10Jun 20, 13[G01N]
2013/0136,786 LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENTABANFeb 09, 12May 30, 13[C12N, C12Q]
2013/0100,272 Multifunction autofocus system and method for automated microscopyABANOct 25, 11Apr 25, 13[H04N]
2013/0084,328 METHYLATED CODING AND NON-CODING RNA GENES AS DIAGNOSTIC AND THERAPEUTIC TOOLS FOR HUMAN MELANOMAABANApr 26, 12Apr 04, 13[C12Q]
2013/0064,799 METHODS FOR PROMOTING CELL REPROGRAMMINGABANMay 31, 12Mar 14, 13[C12N, C40B, G01N, A61K]
2013/0058,993 METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDESABANFeb 28, 12Mar 07, 13[A61P, A61K, B82Y, C07K]
2012/0276,122 METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSABANOct 31, 11Nov 01, 12[C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0269,901 Methods and Compounds Useful to Induce Apoptosis in Cancer CellsABANDec 19, 11Oct 25, 12[A61P, G01N, A61K]
2012/0204,273 COMPOSITIONS RELATING TO A PHOSPHOPROTEIN AND METHODS OF USEABANDec 22, 11Aug 09, 12[C12N, A01K, A61P, C12Q, G01N, A61K]
2012/0196,922 ZNF206: A NOVEL REGULATOR OF EMBRYONIC STEM CELL SELF-RENEWAL AND PLURIPOTENCYABANDec 05, 11Aug 02, 12[C12N, C07H, C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0190,615 METHODS AND COMPOSITIONS FOR INDUCING WEIGHT LOSSABANJan 18, 12Jul 26, 12[A61P, A61K]
8,193,315 Excitatory glycine receptors and methodsExpiredJul 23, 10Jun 05, 12[C07K]
8,188,080 VHR protein tyrosine phosphatase inhibitors, compositions and methods of useExpiredOct 17, 08May 29, 12[C07D, A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.